(Press-News.org) A computer decision model suggests that for patients with a history of bleeding within the brain, the risk of recurrence associated with statin treatment may outweigh the benefit of the drug in preventing cardiovascular disease, according to a report posted online today that will appear in the May print issue of Archives of Neurology, one of the JAMA/Archives journals.
The benefits of statins for reducing the risk of heart disease and stroke are well established, but more widespread use of statin therapy remains controversial, according to background information in the article. "A particular subgroup of patients for whom the advisability of statin use is unclear are those at high risk for intracerebral hemorrhage," or a stroke caused by bleeding within the brain, the authors write. "The reason for added concern is the increased incidence of intracerebral hemorrhage observed among subjects randomized to statin therapy in a clinical trial of secondary stroke prevention."
"Because intracerebral hemorrhage sufferers commonly have co-morbid [co-occurring] cardiovascular risk factors that would otherwise warrant cholesterol-lowering medication, it is important to weigh the risks and benefits of statin therapy in this population," write M. Brandon Westover, M.D., Ph.D., of Massachusetts General Hospital and Harvard Medical School, Boston, and colleagues. The researchers used a Markov decision model to evaluate these benefits and risks. Based on prior research, simulated patients were assigned to states that correspond to disease risk and could then experience any combination of events which may lead to the increased risk of stroke or heart disease, change in quality of life or death.
"Our analysis indicates that in settings of high recurrent intracerebral hemorrhage risk, avoiding statin therapy may be preferred," the authors write. "For lobar intracerebral hemorrhage [bleeding in the cerebrum] in particular, which has a substantially higher recurrence rate than does deep intracerebral hemorrhage, statin therapy is predicted to increase the baseline annual probability of recurrence from approximately 14 percent to approximately 22 percent, offsetting the cardiovascular benefits for both primary and secondary cardiovascular prevention."
In the case of deep intracerebral hemorrhage, a type of stroke due to bleeding deep within the brain that has a lower risk of recurrence, the benefits and risks of statin use were more evenly balanced. "Consequently, the optimal treatment option may vary with specific circumstances," the authors write.
The mechanism by which statins might increase the risk of hemorrhagic stroke are unknown, the authors note. The association may be due to an increased risk of brain bleeding among those with lower cholesterol levels, or potential anti-clotting properties of statins.
"In summary, mathematical decision analysis of the available data suggests that, because of the high risk of recurrent intracerebral hemorrhage in survivors of prior hemorrhagic stroke, even a small amplification of this risk by use of statins suffices to recommend that they should be avoided after intracerebral hemorrhage," the authors conclude. "In the absence of data from a randomized clinical trial (ideally comparing various agents and doses), the current model provides some guidance for clinicians facing this difficult decision."
(Arch Neurol. Published online January 10, 2011. doi:10.1001/archneurol.2010.356. Available pre-embargo to the media at www.jamamedia.org.)
Editor's Note: This work was supported by a grant from the National Institutes of Health. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Editorial: Do No Harm With Statin Treatment
"The question prompting the decision analysis model reported by Westover et al epitomizes a common conundrum faced by clinicians—the need to make a therapeutic decision for a given patient in the absence of guidance from specific, high-quality clinical trial data," writes Larry B. Goldstein, M.D., of Duke University and Durham VA Medical Center, Durham, N.C., in an accompanying editorial.
"In this case, exploratory data from two clinical trials (Heart Protection Study and SPARCL) suggest, but do not prove, a statin-associated increased risk of brain hemorrhage that may reduce the overall benefit of treatment in patients with a history of cerebrovascular disease."
The available data are "generally consistent with the conclusion of the decision analysis—the risk of statin therapy likely outweighs any potential benefit in patients with (at least recent) brain hemorrhage and should generally be avoided in this setting," Dr. Goldstein writes. "Until and unless there are data to the contrary, or warranted by specific clinical circumstances, the use of statins in patients with hemorrhagic stroke should be guided by the maxim of nonmaleficence—Primum non nocere."
(Arch Neurol. Published online January 10, 2011. doi:10.1001/archneurol.2010.349. Available pre-embargo to the media at www.jamamedia.org.)
Editor's Note: This work was supported by a grant from the National Institutes of Health. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
###
To contact corresponding author Steven M. Greenberg, M.D., Ph.D., call Mike Morrison at 617-724-6425 or e-mail mdmorrison@partners.org. To contact editorial author Larry B. Goldstein, M.D., call Melissa Schwarting at 919-660-1303 or e-mail melissa.schwarting@duke.edu.
For more information, contact JAMA/Archives Media Relations at 312/464-JAMA (5262) or e-mail mediarelations@jama-archives.org.
END
Most anti-epileptic drugs are associated with an increased risk of non-traumatic fracture in individuals 50 years of age and older, according to a report in the January issue of Archives of Neurology, one of the JAMA/Archives journals.
Anti-epileptic drugs are considered a secondary risk factor for osteoporosis, according to background information in the article, because epilepsy is highly prevalent in older adults, a population already at risk for osteoporosis. Additionally, anti-epileptic drugs are associated with greater bone density reduction in post-menopausal women ...
An estimated 6.5 percent of Americans age 40 and older have the eye disease age-related macular degeneration, a lower rate than was reported 15 years ago, according to a report in the January issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
"Despite new medical and surgical interventions, age-related macular degeneration (AMD) remains an important cause of loss of vision in the United States," the authors write as background information in the article. The last nationally representative estimates of prevalence of AMD were based on the 1988-1994 Third ...
An implant that releases the medication dexamethasone within the eye appears safe and effective for the treatment of some types of uveitis (swelling and inflammation in the eye's middle layer), according to a report posted online today that will appear in the May print issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
"Uveitis refers to a group of intraocular inflammatory diseases that cause 10 percent to 15 percent of blindness in the developed world," the authors write as background information in the article. "Despite advances in immunosuppressive ...
Bottle rockets can cause significant eye injuries in children, often leading to permanent loss of vision, according to a report posted online today that will appear in the May print issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
Of the estimated 9,200 emergency department admissions resulting from fireworks-related injuries each year, about 1,400 cases involve the eyes, according to background information in the article. A disproportionate number of these injuries are caused by bottle rockets. Bottle rockets are about half the size of a normal ...
Although the 2009 H1N1 influenza pandemic infected an estimated 60 million people and hospitalized more than 250,000 in the United States, it also brought one significant benefit—clues about how to make a vaccine that could protect against multiple strains of influenza.
In the Jan. 10, 2011, issue of the Journal of Experimental Medicine, researchers from the University of Chicago and Emory University report that people who were infected with pandemic H1N1 and recovered had an extraordinary immune response, producing antibodies that are protective against a variety of ...
All secondary school students should be required to be trained in cardiopulmonary resuscitation (CPR) and receive an overview of automated external defibrillators (AEDs), according to an American Heart Association science advisory.
The advisory, published in Circulation: Journal of the American Heart Association, calls for state legislatures to mandate that CPR and AED training be required for graduation, and to provide funding and other support to ensure the educational standard is met.
Last school year, 36 states had a law or curriculum standard encouraging CPR training ...
If you smoke around your children, they could have high blood pressure or be headed in an unhealthy direction before learning their ABC's, according to research reported in Circulation: Journal of the American Heart Association.
The study is the first to show that breathing tobacco smoke increases the blood pressure of children as young as 4 or 5 years old.
"The prevention of adult diseases like stroke or heart attack begins during childhood," said Giacomo D. Simonetti, M.D., first author of the study at the University of Heidelberg in Germany and currently assistant ...
Teenagers who consume a lot of added sugars in soft drinks and foods may have poor cholesterol profiles — which may possibly lead to heart disease in adulthood, according to first-of-its-kind research reported in Circulation: Journal of the American Heart Association.
"Added sugars" are any caloric sweeteners added to foods or beverages by the manufacturer during processing or the consumer.
The National Health and Nutrition Survey (NHANES) of 2,157 teenagers (ages 12 to 18) found the average daily consumption of added sugars was 119 grams (28.3 tsp or 476 calories), ...
According to an Emory University study, teenagers with high sugar diets may be in store for heart problems as adults.
A study published in the Jan. 10 online issue of the journal Circulation finds teens who consume elevated amounts of added sugars in drinks and foods are more likely to have poor cholesterol and triglyceride profiles now which may lead to heart disease later in life.
The study also finds that overweight or obese teens with the highest levels of added sugar intake had increased signs of insulin resistance, often a precursor to diabetes.
According to ...
Melt off from small mountain glaciers and ice caps will contribute about 12 centimetres to world sea-level increases by 2100, according to UBC research published this week in Nature Geoscience.
The largest contributors to projected global sea-level increases are glaciers in Arctic Canada, Alaska and landmass bound glaciers in the Antarctic. Glaciers in the European Alps, New Zealand, the Caucasus, Western Canada and the Western United Sates--though small absolute contributors to global sea-level increases--are projected to lose more than 50 per cent of their current ice ...
